SCHEMBL8277255

SCHEMBL8277255

COC(=O)c1oc2ccc([S+]([O-])Cl)cc2c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.50
ALDH1A1 P00352 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
HPGD P15428 3/20 0.50
TP53 P04637 1/20 0.47
HTT P42858 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MKNK2 Q9HBH9 1/20 0.45
MCL1 Q07820 1/20 0.45
KCNH2 Q12809 3/20 0.44
MAPK1 P28482 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
HIF1A Q16665 3/20 0.43
CELA1 Q9UNI1 1/20 0.43
PARG Q86W56 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1155916 0.77 PARG (0.54) KDM4EALDH1A1SMN1; SMN2HPGDTP53
SCHEMBL724096 0.76 MAPT (0.64) KDM4EALDH1A1SMN1; SMN2HPGDTP53
SCHEMBL719907 0.76 KDM4E (0.76) KDM4EALDH1A1SMN1; SMN2HPGDTP53
SCHEMBL28417797 0.76 KDM4E (0.59) KDM4EALDH1A1SMN1; SMN2HPGDTP53
SCHEMBL717905 0.76 KCNH2 (0.67) KDM4EALDH1A1SMN1; SMN2HPGDTP53
SCHEMBL6982862 0.75 HIF1A (0.57) KDM4EALDH1A1SMN1; SMN2HPGDTP53
SCHEMBL3499961 0.75 KDM4E (0.61) KDM4EALDH1A1SMN1; SMN2HPGDTP53
SCHEMBL719418 0.74 KCNH2 (0.52) KDM4EALDH1A1SMN1; SMN2HPGDTP53
SCHEMBL24641442 0.73 HIF1A (0.53) KDM4EALDH1A1HPGDHSD17B10HIF1A
SCHEMBL15714086 0.73 HIF1A (0.58) KDM4EALDH1A1SMN1; SMN2HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006010008-A1 HETEROCYCLIC DERIVATIVES FOR MODULATION OF CALCIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-01-26 WO disclosed